Cardiocutaneous syndrome is caused by aggregation of iASPP mutants
2024

Understanding Cardiocutaneous Syndrome Caused by iASPP Mutations

publication Evidence: moderate

Author Information

Author(s): Rebecca Lotz, Christian Osterburg, Birgit Schäfer, Xin Lu, Volker Dötsch

Primary Institution: Goethe University, Frankfurt, Germany

Hypothesis

How do mutations in iASPP lead to cardiocutaneous syndromes?

Conclusion

The study reveals that iASPP mutations can cause cardiocutaneous syndromes through mechanisms involving protein aggregation and loss of function.

Supporting Evidence

  • iASPP mutations linked to cardiomyopathy are prone to aggregation.
  • Mutations in iASPP do not cluster in specific hotspots but are distributed across the entire protein.
  • Missense mutations found in cancer do not result in aggregation.

Takeaway

Some changes in a protein called iASPP can make it clump together, which can lead to serious health problems in kids, like heart and skin issues.

Methodology

The study analyzed the stability and solubility of iASPP mutants, characterized their interaction with chaperones, and investigated their influence on NF-ĸB activity.

Digital Object Identifier (DOI)

10.1038/s41420-024-02265-z

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication